143 related articles for article (PubMed ID: 25546799)
1. Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency.
Rojavin M; Sidhu J; Pfister M; Hubsch A
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):146-8. PubMed ID: 25546799
[No Abstract] [Full Text] [Related]
2. Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.
von Gunten S
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):151-2. PubMed ID: 25546801
[No Abstract] [Full Text] [Related]
3. Europe immunoglobulin map.
Šedivá A; Chapel H; Gardulf A;
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):141-3. PubMed ID: 25546797
[No Abstract] [Full Text] [Related]
4. 7th International Immunoglobulin Conference: Poster presentations.
Warnatz K; Ballow M; Stangel M; Bril V
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805
[TBL] [Abstract][Full Text] [Related]
5. IgG replacement therapy, no size fits all.
Bonilla FA
Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364
[No Abstract] [Full Text] [Related]
6. Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?
Baumann U; Miescher S; Vonarburg C
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):83-5. PubMed ID: 25546772
[No Abstract] [Full Text] [Related]
7. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Shapiro RS
Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
[TBL] [Abstract][Full Text] [Related]
8. 7th International Immunoglobulin Conference: Immunoglobulin in clinical practice.
Shapiro RS; Borte M
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):86. PubMed ID: 25546773
[TBL] [Abstract][Full Text] [Related]
9. Reversible Hypogammaglobulinemia in 2 Pediatric Patients With Primary Immunodeficiency.
Pasic S
J Investig Allergol Clin Immunol; 2017; 27(5):320-321. PubMed ID: 29057740
[No Abstract] [Full Text] [Related]
10. [Antibodies: biology and clinical use].
De Martino M; Rossi ME; Vierucci A
Ann Sclavo Collana Monogr; 1984; 1(1):1-305. PubMed ID: 6546001
[No Abstract] [Full Text] [Related]
11. Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease.
Melamed I; Testori A; Spirer Z
Int Rev Immunol; 2012 Dec; 31(6):451-61. PubMed ID: 23215767
[TBL] [Abstract][Full Text] [Related]
12. Dose and outcomes in primary immunodeficiency disorders.
Bonagura VR
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):7-9. PubMed ID: 25546743
[No Abstract] [Full Text] [Related]
13. [Subcutaneous immunoglobulin substitution and therapy].
Gulácsy V; Maródi L
Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
[TBL] [Abstract][Full Text] [Related]
14. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
McCormack PL
BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
[TBL] [Abstract][Full Text] [Related]
15. Persistent Skin Pouches Following Subcutaneous Immunoglobulin Infusions in a Girl with Immunodeficiency, Bullous Skin Lesions and Melanosis Oculi.
Krüger R; Feiterna-Sperling C; Blume-Peytavi U; Lala B; von Bernuth H; Wahn V
J Clin Immunol; 2017 Aug; 37(6):505-507. PubMed ID: 28624913
[No Abstract] [Full Text] [Related]
16. [Use of intravenous and subcutaneous human immunoglobulins].
Ramus B; Benbrahim O; Chérin P
Soins; 2019 Mar; 64(833):13-18. PubMed ID: 30879622
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.
Berger M; Rojavin M; Kiessling P; Zenker O
Clin Immunol; 2011 May; 139(2):133-41. PubMed ID: 21353644
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
[TBL] [Abstract][Full Text] [Related]
19. Another subcutaneous immune globulin (Cuvitru) for primary immunodeficiency.
Med Lett Drugs Ther; 2017 May; 59(1521):e88-e89. PubMed ID: 28520701
[No Abstract] [Full Text] [Related]
20. Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies.
Seppänen M
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):10-3. PubMed ID: 25546744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
